Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples